Immunovant, Inc. (IMVT)
26.66
-0.06
(-0.22%)
USD |
NASDAQ |
Mar 06, 16:00
26.65
-0.01
(-0.04%)
After-Hours: 20:00
Immunovant Cash from Investing (TTM) : -0.201M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Boston Scientific Corp. | -2.64B |
| Viridian Therapeutics, Inc. | -37.56M |
| Plus Therapeutics, Inc. | 0.287M |
| Nutriband, Inc. | -0.0053M |
| Definium Therapeutics, Inc. | -151.92M |